Company Filing History:
Years Active: 2012-2013
Title: Emma Louise Palfreyman: Innovator in Hematopoietic Cell Production
Introduction
Emma Louise Palfreyman is a distinguished inventor based in Fig Tree Pocket, Australia. She has made significant contributions to the field of cell biology, particularly in the production of hematopoietic cells. With a total of 2 patents, her work is paving the way for advancements in medical treatments.
Latest Patents
Emma's latest patents include innovative methods for producing specific populations of cells. The first patent, titled "Method of producing a population of cells," describes an in vitro or ex vivo technique for generating lineage-committed hematopoietic progenitor or mature hematopoietic cells. This method involves culturing hematopoietic progenitor cells in a specialized animal cell culture medium enriched with cytokines. The process ensures that the cells are agitated under conditions that promote their growth and differentiation into the desired cell types.
The second patent, "Method of producing a population of post-mitotic cells of the neutrophil lineage," outlines a method for generating post-mitotic neutrophil cells. This technique includes providing a population of neutrophil progenitor cells and culturing them in a medium that supports their differentiation into a neutrophil-specific lineage. The resulting population of cells can be utilized to enhance the number of neutrophils in patients, which is crucial for various therapeutic applications.
Career Highlights
Emma is affiliated with The University of Queensland, where she conducts her research and development work. Her innovative approaches to cell production have garnered attention in the scientific community, contributing to advancements in hematology and regenerative medicine.
Collaborations
Emma collaborates with notable colleagues, including Nicholas Eion Timmins and Lars K Nielsen. Their combined expertise enhances the research efforts and fosters a collaborative environment for innovation.
Conclusion
Emma Louise Palfreyman is a remarkable inventor whose work in hematopoietic cell production is making a significant impact in the field of medicine. Her patents reflect her dedication to advancing scientific knowledge and improving patient outcomes.